UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 38

of 'Molecularly targeted therapy for metastatic melanoma'

38
TI
Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
AU
Long GV, Grob JJ, Nathan P, et al
SO
Lancet Oncol. 2016;
 
AD